Over 1900 Total Lots Up For Auction at Two Locations - NJ Cleansweep 06/13, NJ 06/14

Purchasing insights on ultrasound systems

May 06, 2024
Ultrasound

Additional vendors
Additional vendors in the general market category include Mindray, Canon, Samsung and Siemens. These vendors make up less than 10% of the purchasing activity seen by symplr.

AI-based software in ultrasound
stats
DOTmed text ad

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

stats

Artificial Intelligence (AI) is emerging as an invaluable tool to assist sonographers. AI technology in ultrasound software is crafted to function discreetly as clinicians capture images, operating seamlessly in the background to locate and determine the most suitable images for specific applications as required by the user. AI can help automate imaging processes from acquisition to analysis, assist and improve diagnostic accuracy, and reduce costs.

According to Philips Healthcare, their LVivo Seamless from DiA Imaging analysis, a Philips company, is a 510k cleared feature for the Philips CV Ultrasound system. This software is identified in their premium Epiq CVx machine, of which symplr has identified as being included in 69% of quotes analyzed in the premium cardiac ultrasound technology.

GE HealthCare has several AI-based software applications to assist the sonographer. One of the systems symplr has identified in 46% of quotes analyzed in the last 12 months is the Voluson Expert. According to GE Healthcare, with the assistance of SonoLyst, a suite of tools is available on the Voluson systems, this reduces second trimester exam times by up to 40%. AI identifies fetal anatomy seen on standard view, then automatically annotates and measures where applicable.

The ultrasound market is expected to continue growing as benefits like cost and safety will be coupled with AI-driven improvements and offer more accessible, cost-effective options compared to CT and MR technologies.

About the author: Rachel Stolpa is a clinical analyst with symplr.

Back to HCB News

You Must Be Logged In To Post A Comment